Nexstim Plc

NXTMH

FI4000506811

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Helsinki Other stock markets 08:59:44 31/05/2024 pm IST			5-day change	1st Jan Change
2.78 ^EUR	-0.71%		-0.36%	-5.44%

08/05	Nexstim Plc Receives an Order for an NBS System 5 from a Hospital in Finland	CI
06/05	Nexstim plc Receives Approval from Health Canada for the Marketing and Commercial Distribution of Its NBS 6 System for the Treatment of Major Depressive Disorder	CI

Nexstim plc Appoints Mikko Karvinen as Permanent CEO

June 16, 2020 at 09:35 pm IST

Nexstim Plc announces that the Board of Directors has appointed, effective immediately, the current interim CEO Mikko Karvinen as permanent CEO.

Latest news about Nexstim Plc

Nexstim Plc Receives an Order for an NBS System 5 from a Hospital in Finland	08/05	CI
Nexstim plc Receives Approval from Health Canada for the Marketing and Commercial Distribution of Its NBS 6 System for the Treatment of Major Depressive Disorder	06/05	CI
Nexstim plc Receives Order for A New NBS System 5 from an Existing Customer Hospital in Germany	26/04	CI
Nexstim Wins Order for Navigated Brain Stimulation System in US	22/04	MT
Nexstim Receives NBS 6 System Order from Clinic in Florida, US	22/04	CI
Nexstim Receives NBS System 5 Order from Neurosurgery Customer in Germany	28/02	CI
Transcript : Nexstim Plc, 2023 Earnings Call, Feb 27, 2024	27/02
Nexstim Plc Provides Sales Guidance for the Year 2024	27/02	CI
Nexstim Plc Reports Earnings Results for the Full Year Ended December 31, 2023	27/02	CI
Finland’s Nexstim Bags Brain Stimulation System Order From US	10/01	MT
Nexstim Receives NBS System 5 Order from Healthcare Services Group in the US	10/01	CI
Nexstim Secures Minority Stake in US-based Management Services Organization	04/01	MT
Nexstim Plc Updates Earnings Guidance for the Year 2023	02/01	CI
Nexstim Receives Nexstim NBS System 5 Order from Distributor in Europe	29/12	CI
Nexstim Wins Order for Brain Simulation System in Europe	29/12	MT
Nexstim Plc Receives Nexstim NBS System 5 Order from Europe for Neurosurgery and Neuroscience Use	22/12	CI
Finland's Nexstim Receives Order for NBS 6 Systems	21/12	MT
Nexstim Plc Receives Order for Two NBS 6 Systems from Distributor	21/12	CI
Nexstim Plc Receives an NBS (Navigated Brain Stimulation) 6 System Order from the Center for Integrative Neuroscience, A New Clinic Located in Traverse City, Michigan	20/12	CI
Finland’s Nexstim Secures Brain Stimulation System Order From Germany	19/12	MT
Hospital in Germany Orders Nexstim NBS System 5	19/12	CI
Nexstim Plc Releases New System Functionalities for Research Use in Europe	04/12	CI
Nexstim Receives NBS System 6 Order from Hospital in United States	20/11	CI
Nexstim plc Announces Board Appointments	24/23/24	CI
Nexstim Wins Order for Navigated Brain Stimulation System in Finland	20/23/20	MT

Nexstim Oyj is a Finland-based medical technology company. It is focused on improving rehabilitation for stroke patients through the use of noninvasive brain stimulation. Its offering comprises: a diagnostic tool for brain surgery planning, Navigated Brain Stimulation (NBS) System, which comprises navigated transcranial magnetic stimulation (nTMS) device for presurgical mapping (PSM) of the motor and speech cortices; and a device for stroke therapy called Navigated Brain Therapy (NBT) System, which focuses stimulation on targeted locations in the brain in order to enhance rehabilitation process. The NBT System targets upper limb motor disability and is under Phase III pivotal clinical trial study at rehabilitation sites in the United States. The Companyâs systems are used in over 100 facilities in research, therapy and neurosurgical planning purposes. Nexstim Oyj has two subsidiaries: Nexstim Inc and Nexstim Germany GmbH.

Sector

Advanced Medical Equipment & Technology

Calendar

09/06/2024 - German Society for Neurosurgery Meeting

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

2.8 EUR

Average target price

3 EUR

Spread / Average Target

+7.14%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
NEXSTIM PLC	-5.44%	2.05Cr
THERMO FISHER SCIENTIFIC	+6.20%	21TCr
DANAHER CORPORATION	+9.72%	19TCr
INTUITIVE SURGICAL, INC.	+17.97%	14TCr
BOSTON SCIENTIFIC CORPORATION	+29.40%	11TCr
SIEMENS HEALTHINEERS AG	+1.48%	6.47TCr
EDWARDS LIFESCIENCES CORPORATION	+12.85%	5.3TCr
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-0.16%	4.98TCr
AGILENT TECHNOLOGIES, INC.	-6.15%	3.83TCr
GE HEALTHCARE TECHNOLOGIES INC.	+0.57%	3.59TCr

Other Advanced Medical Equipment & Technology

Nexstim Plc

Equities

NXTMH

FI4000506811

Advanced Medical Equipment & Technology

Nexstim plc Appoints Mikko Karvinen as Permanent CEO

Latest news about Nexstim Plc

Chart Nexstim Plc

Company Profile

Income Statement Evolution

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Advanced Medical Equipment & Technology